Return on Tangible Equity (Quarterly)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Cytokinetics, Incorporated (CYTK) had Return on Tangible Equity of 36.44% for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$66.77M
Net Income	$-134.37M
Cost of Goods Sold	--
Gross Profit	$66.77M
Operating Expenses	$178.28M
Operating Income	$-111.51M
Non-Operating Income/Expense	$-22.86M
Pre-Tax Income	$-134.37M
Normalized Pre-Tax Income	$-134.37M
Income after Taxes	$-134.37M
Income from Continuous Operations	$-134.37M
Consolidated Net Income/Loss	$-134.37M
Normalized Income after Taxes	$-134.37M
EBIT	$-111.51M
EBITDA	$-109.22M
Weighted-Average Shares Outstanding (Basic)	119.46M
Weighted-Average Shares Outstanding (Diluted)	119.46M
Earnings per Share (EPS) (Basic)	$-1.12
Earnings per Share (EPS) (Diluted)	$-1.12
Balance Sheet Financials
Current Assets	$886.54M
Property, Plant, and Equipment	$70.22M
Long-Term Assets	$339.09M
Total Assets	$1.23B
Current Liabilities	$131.06M
Long-Term Debt	$713.04M
Long-Term Liabilities	$1.46B
Total Liabilities	$1.59B
Common Equity	$-368.72M
Tangible Shareholders Equity	$-368.72M
Shareholders Equity	$-368.72M
Common Shares Outstanding	119.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-259.85M
Cash Flow from Investing Activities	$158.84M
Cash Flow from Financial Activities	$83.29M
Beginning Cash	$95.23M
End Cash	$76.55M
Increase/Decrease in Cash	$-18.68M
Stock-Based Compensation	$51.08M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.76
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.07
Debt to Equity Ratio	-1.97
Gross Margin	100.00%
Operating Margin	-167.00%
EBIT Margin	-167.00%
EBITDA Margin	--
Pre-Tax Profit Margin	-201.25%
Profit Margin	-201.25%
Free Cash Flow	$-269.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.05
Inventory Turnover	--
Receiveable Turnover	7.94
Days Sales in Receivables	11.34
Return on Equity	36.44%
Return on Tangible Equity	36.44%
Return on Assets	-10.96%
Return on Investments	-39.02%
Book Value Per Share	$-3.08
Free Cash Flow per Share	$-2.26
Operating Cash Flow per Share	$-2.18

Data from Zacks Investment Research, Inc.